Stock Market & Financial Investment News

News Breaks January 14, 2013 07:10 EDT CELG Celgene price target raised to $115 from $96 at Cantor Cantor increased its target on Celgene after the company raised its guidance last week. The firm also increased its target based on its optimism about the company's ABRAXANE and apremilast drugs, and it maintains a Buy rating on the stock. News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 09:51 EDT CELG Celgene management to meet with JPMorgan Meetings to be held in Boston on May 22-23 hosted by JPMorgan. May 17, 2013 05:51 EDT CELG Stocks with implied volatility movement; CBST CELG Subscribe for More Information May 16, 2013 11:50 EDT CELG Celgene, Gilead lower after new data published at ASCO Subscribe for More Information May 7, 2013 07:18 EDT CELG Barclays has increased confidence in Celgene's re-filing of Revlimid Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.